ANI Pharmaceuticals Inc

Company Snapshot
210 Main Street West
Baudette, MN 56623
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 600
https://www.anipharmaceuticals.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$121,318,000
$115,526,000
$177,600,000
Operating Income
($15,570,000)
($28,169,000)
($25,734,000)
Net Income
($22,548,000)
($42,603,000)
($47,896,000)
2020
Gross Profit
$121,318,000
Operating Income
($15,570,000)
Net Income
($22,548,000)
2021
Gross Profit
$115,526,000
Operating Income
($28,169,000)
Net Income
($42,603,000)
2022
Gross Profit
$177,600,000
Operating Income
($25,734,000)
Net Income
($47,896,000)
The above data on ANI Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Nikhil Lalwani
Director, President and Chief Executive Officer
$2,157,347
$4,369,205
$14,508
$6,541,060
Nikhil Lalwani
$6,541,060
Director, President and Chief Executive Officer
Stephen Carey
Senior Vice President Finance, Principal Accounting Officer and Chief Financial Officer
$1,085,319
$1,743,585
$21,650
$2,850,554
Stephen Carey
$2,850,554
Senior Vice President Finance, Principal Accounting Officer and Chief Financial Officer
James Marken
Senior Vice President Operations and Product Development
$695,876
$1,025,632
$13,145
$1,734,653
James Marken
$1,734,653
Senior Vice President Operations and Product Development
Christopher Mutz
Chief Commercial Officer and Head of Rare Diseases
$585,944
$1,016,120
$9,231
$1,611,295
Christopher Mutz
$1,611,295
Chief Commercial Officer and Head of Rare Diseases
Ori Gutwerg
Senior Vice President Generics
$710,744
$808,593
$0
$1,519,337
Ori Gutwerg
$1,519,337
Senior Vice President Generics
ANI Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2021. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us